Top compounds associated with response to LRRC26

Feature Type	Compound	Dataset	Tissue	Stat	Standardized Coefficient	Nominal ANOVA p-value
mRNA	SGX-523	CTRPv2	pan-cancer	AAC	0.035	0.4
mRNA	tivozanib	CTRPv2	pan-cancer	AAC	-0.034	0.4
mRNA	vorinostat:navitoclax (4:1 mol/mol)	CTRPv2	pan-cancer	AAC	0.035	0.4
mRNA	Nutlin-3	CTRPv2	pan-cancer	AAC	0.032	0.4
mRNA	salermide	CTRPv2	pan-cancer	AAC	-0.043	0.4
mRNA	salermide:PLX-4032 (12:1 mol/mol)	CTRPv2	pan-cancer	AAC	-0.034	0.4
mRNA	dabrafenib	CTRPv2	pan-cancer	AAC	-0.051	0.4
mRNA	tamatinib	CTRPv2	pan-cancer	AAC	-0.034	0.4
mRNA	ABT-737	CTRPv2	pan-cancer	AAC	-0.033	0.4
mRNA	BRD-K61166597	CTRPv2	pan-cancer	AAC	0.029	0.4

Download CSV